Atezolizumab recommended by NICE for triple-negative breast cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Costs in warfarin-sensitive versus warfarin-insensitive patients
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Care-giver burden substantial in Duchenne muscular dystrophy in Spain
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Plerixafor costly choice for PBSC mobilisation in multiple myeloma
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

BRCA testing prevention cost better than cure in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Cannabinoid oil cost-effective choice for Dravet syndrome in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Substantial economic burden of RSV hospitalisations in Columbian infants
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Adjuvant pembrolizumab cost effective for stage  III melanoma
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Evidence of importance of patient-reported outcomes in cancer trials
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Whole genome sequencing infection prevention program cost effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Trauma service use for minimal injuries increases cost, decreases value
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Cost of care conversations in cancer patients
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Novel oral regimens cost effective for HCV infections in adolescents
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Impact of COVID-19 pandemic on HTA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Simulation modelling aids Girl Scouts Fierce & amp; Fit programme design in US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Biennial screening for retinopathy may be cost effective in diabetes
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Ceftazidime/avibactam cost effective in hospital-acquired pneumonia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Baricitinib may be cost effective as part of RA treatment strategy
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Erice Call for Change: enhancing quality and safety of care
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Substantial direct medical costs for symptomatic COVID-19 cases in the US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Improved adherence with extended-release metformin for T2DM in US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Patient views of moving codeine to being a prescription-only medicine in Australia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

ACA Medicaid expansion reduces uninsured rate in cancer survivors
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Watchful observation vs aspiration cytology for small thyroid nodules
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Hospital burden of RSV infection similar to influenza in older adults
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Cost of CAR T-cell therapy varies by site of care in the US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Sodium bicarbonate not cost effective for CKD with acidosis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Cost burden may contribute to early discontinuation of buprenorphine
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Tofacitinib may reduce US payer costs for active PsA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Disparate out-of-pocket cancer care costs in Western Australia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Productivity loss drives economic burden of COPD in Malaysia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Assessing costs of vaginal anti-incontinence procedures in the US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Assessing value of therapies for comorbid obesity and depression
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Costs vs benefits of tackling COVID-19
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Impact of organ involvement on healthcare utilisation for systemic sclerosis in England
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Lifetime costs of unilateral cochlear implantation in Germany
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Monetary valuation of a QALY in Saudi Arabia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2020 Category: Drugs & Pharmacology Source Type: news

Methotrexate vs curettage for low-risk gestational trophoblastic neoplasia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Comprehensive HBV programme has positive return on investment
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Increased prescribing of newer GLD classes in older Australians from 2013 to 2016
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Free asthma medications reduce hospitalisations and costs in Brazil
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

AI-assisted diagnosis of polyps reduces colonoscopy costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Cost savings with pharmacist-led dosage adjustments in renal patients in Thailand
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Cytotoxic chemotherapy increases costs but not survival in recurrent ovarian cancer in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

SMC approves four new medicines for NHS Scotland
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Costs of testing for inherited thrombophilia reduced by Choosing Wisely
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Mifepristone & quot;valuable addition & quot; to early pregnancy loss management in US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Cost effectiveness of interventions required for ending HIV epidemic
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

Cost burden of dementia in USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news

HER2-positive MBC has high short- and medium-term costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2020 Category: Drugs & Pharmacology Source Type: news